SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses
SIGA Technologies, a commercial stage pharmaceutical company, announced that its antiviral treatment Tepoxx (tecovirimat 200 mg capsules), marketed as Tpoxx in the United States, has received regulatory approval in Japan for the treatment of smallpox, mpox …